Bright Minds Biosciences Inc. DRUG · SEC Filings

website

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives o...

Price24.11

Market Cap240.86 M

Float8.21 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 12, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jan 7, 2026

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

Jan 6, 2026

F-3

August 2025 SHELF & ATM

Aug 25, 2025

F-3

Form F-3 - Registration statement by foreign private issuers

Feb 5, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Nov 19, 2024

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

Cormorant Asset Management, LP (Filed by)

Aug 14, 2026

SCHEDULE 13G/A

Adage Capital Management, L.P. (Filed by)

Aug 12, 2026

SCHEDULE 13D/A

McDonald Ian (Filed by)

Jul 2, 2026

SCHEDULE 13G

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

May 15, 2026

SCHEDULE 13G/A

JANUS HENDERSON GROUP PLC (Filed by)

May 15, 2026

SCHEDULE 13G/A

JANUS HENDERSON GROUP PLC (Filed by)

May 15, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Sep 3, 2025

CORRESP

Form CORRESP - Correspondence

Aug 28, 2025

LETTER

Form UPLOAD - SEC-generated letter

Aug 27, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Feb 18, 2025

CORRESP

Form CORRESP - Correspondence

Feb 12, 2025

LETTER

Form UPLOAD - SEC-generated letter

Feb 11, 2025